Strong Dupixent Trajectory Anchors Regeneron Pharmaceuticals' (REGN) Solid Financial Results
Longleaf Partners, managed by Southeastern Asset Management, released its third-quarter 2026 investor letter for its “Partners Fund”. The letter can be downloaded here.





